Potentially Inappropriate Medications and the Risk of Adverse Drug Events in Older Patients
A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Medication Management".
Deadline for manuscript submissions: closed (31 December 2024) | Viewed by 14214
Special Issue Editors
2. Faculty of Medicine, Autonomous University of Madrid, Arzobispo Morcillo sn, 28049 Madrid, Spain
Interests: pharmacology and therapeutics; clinical pharmacology; pharmacovigilance; adverse drug reactions; adverse drug events
Interests: clinical pharmacy
Special Issue Information
Dear Colleagues,
Older people comprise approximately 13% of the population; however, they consume 40% of prescription drugs and 35% of all over-the-counter drugs. The older population are particularly susceptible to adverse drug events or drug interactions, due to the physiological changes they experience, genetic predisposition, and environmental exposure. It is necessary to adapt health systems with comprehensive and multidisciplinary approaches suitable for older patients, since knowledge about proper prescription, clinical pharmacology and the use of medications in the elderly has become essential.
This Special Issue invites research to attempt to explore the adverse effects of medications in elderly patients, and to analyze the prescribers' adherence to appropriate prescribing guidelines in elderly patients. Original research, reviews, and short communications are all welcome.
Since the journal is multidisciplinary in nature, we encourage the submission of interdisciplinary papers and collaborative research from different (low, middle, and high income) countries.
Prof. Dr. Elena Ramírez
Dr. Olga Laosa
Dr. Laura Pedraza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacovigilance
- elderly
- adverse drug reactions
- adverse drugs events
- inappropriate prescribing
- patient safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.